Surgical Oncology · Multiple Cancers

Minimally Invasive Cancer Surgery in Chandigarh

Precision minimally invasive cancer surgery in Chandigarh — performed by a senior surgical oncologist with 20+ years of experience, 5,000+ surgeries and access to robotic and minimally invasive platforms.

Minimally Invasive Cancer Surgery

Overview

Minimally Invasive Cancer Surgery refers to the surgical removal of multiple cancers and involved surrounding tissues to achieve complete tumour clearance while preserving as much healthy anatomy and function as possible. It is often the single most important treatment for solid tumours, offering the best chance of long-term cure when the disease is localised or locally advanced. In modern surgical oncology, minimally invasive cancer surgery is planned as part of a multidisciplinary strategy where medical oncologists, radiation oncologists, radiologists and pathologists work together to sequence treatment optimally.

The philosophy that guides every minimally invasive cancer surgery in our practice is simple: the first surgery is your best surgery. This is why patients travel from Chandigarh, Mohali, Panchkula, Ambala, Delhi and across North India for their first — and definitive — cancer operation.

Symptoms That May Lead to This Surgery

Patients presenting for minimally invasive cancer surgery typically report one or more of the following: a new lump or swelling, unexplained pain, unintentional weight loss, persistent fatigue, changes in bowel or bladder habits, difficulty swallowing, hoarseness, persistent cough, blood in stool or urine, non-healing ulcers, changes in a mole, or abnormalities detected during a routine screening or imaging study. Any symptom persisting beyond a few weeks deserves a medical evaluation.

Causes and Risk Factors

The exact cause of most cancers is multifactorial and includes genetic predisposition, lifestyle (tobacco, alcohol, diet, obesity, sedentary living), chronic infections (H. pylori, HPV, HBV, HCV), occupational or environmental exposures, hormonal factors and ageing. Family history of cancer, exposure to radiation, and certain pre-cancerous conditions also increase risk. Understanding these factors helps guide screening and prevention.

Diagnosis

Diagnosis begins with a detailed clinical evaluation and history. Investigations may include ultrasound, CT scan, MRI, PET-CT, endoscopy, mammography or specialised imaging depending on the site. A tissue biopsy — via needle, endoscopy or minor surgical procedure — is essential to confirm cancer, determine its subtype and guide treatment. Molecular and immunohistochemistry studies are increasingly used to personalise decisions. Staging investigations then determine the extent of disease and the best sequence of treatment.

Treatment Options

Depending on stage and biology, treatment may include surgery alone, surgery combined with chemotherapy and/or radiotherapy, targeted therapy, immunotherapy or hormone therapy. In many cases, minimally invasive cancer surgery is the anchor of treatment. For early-stage disease, surgery may be curative. For locally advanced disease, neoadjuvant therapy is often given first to shrink the tumour, followed by surgery. For metastatic disease, surgery may still play a role in symptom control or in oligometastatic settings.

Who Needs Minimally Invasive Cancer Surgery?

Candidates typically include patients with biopsy-proven cancer of the multiple cancers, imaging confirming a resectable tumour, adequate general fitness for anaesthesia, and clearance from the multidisciplinary tumour board. Age is not an absolute barrier — well-optimised elderly patients undergo minimally invasive cancer surgery safely with excellent outcomes. Patients with borderline resectable or locally advanced tumours may need chemotherapy or chemoradiation first.

The Procedure

Minimally Invasive Cancer Surgery can be performed by open, laparoscopic, thoracoscopic or robotic approaches depending on the site, size and stage of the tumour. The surgery typically involves removal of the primary tumour with adequate margins, systematic lymph node dissection where indicated, and reconstruction to preserve function and quality of life. Nerve-sparing, organ-preservation and reconstructive techniques are utilised wherever oncologically safe. Intra-operative imaging, frozen-section pathology and enhanced-recovery-after-surgery (ERAS) protocols further improve outcomes.

Robotic and minimally invasive advantage: smaller incisions, less blood loss, less pain, shorter hospital stay, faster return to work — with the same oncological safety as open surgery in the right patient.

Preparation Before Surgery

Preparation includes a pre-anaesthetic check-up, blood tests, ECG, imaging, nutritional optimisation, incentive spirometry, smoking and alcohol cessation, control of diabetes and blood pressure, and psychological counselling. Certain blood thinners are stopped a few days before surgery. Our care coordinators guide you through every step, from admission planning to insurance approvals.

Recovery After Minimally Invasive Cancer Surgery

Recovery is guided by ERAS pathways designed to help you eat, walk and breathe deeply early after surgery. Most patients begin sips of water within hours, walk on day 1 and progress to a normal diet within 2–3 days. Pain is controlled by multimodal analgesia. Drains and catheters are removed as early as safely possible. You will be discharged with clear instructions, a wound care plan and a follow-up schedule.

Risks and Possible Complications

Every surgery carries risks: bleeding, infection, anaesthesia-related issues, blood clots, delayed healing, and site-specific complications such as anastomotic leak, voice change, hormonal deficiency, urinary or bowel changes depending on the operation. At high-volume centres with experienced surgeons and modern intensive care, these risks are minimised. Every complication has a defined management plan.

Benefits of Minimally Invasive Cancer Surgery

  • Best chance of long-term cure for resectable multiple cancers
  • Definitive staging and tissue for molecular studies
  • Symptom relief and improved quality of life
  • Preservation of organ function wherever possible
  • Access to advanced robotic and minimally invasive options
  • Multidisciplinary planning tailored to your case

Follow-Up and Long-Term Care

Follow-up typically involves clinic visits every 3 months for the first 2 years, every 6 months up to year 5, and annually thereafter — along with periodic imaging, tumour markers and endoscopy where relevant. Survivorship care includes rehabilitation, nutrition, mental health support and screening for late effects and second cancers.

Frequently Asked Questions

Who needs minimally invasive cancer surgery?
Minimally Invasive Cancer Surgery is recommended for patients diagnosed with multiple cancers where the tumour is surgically resectable — either localised, locally advanced, or as part of a multimodal plan combining chemotherapy and radiotherapy. Suitability is confirmed by imaging, biopsy, staging and multidisciplinary tumour-board discussion.
Is minimally invasive cancer surgery safe?
With an experienced surgical oncology team, modern equipment, high-volume expertise and structured perioperative pathways, minimally invasive cancer surgery is remarkably safe. Complication rates at high-volume centres are considerably lower than national averages.
How long is recovery after minimally invasive cancer surgery?
Hospital stay usually ranges from 2 to 7 days depending on the approach (open, laparoscopic or robotic). Most patients return to daily activities within 2–4 weeks, and to work within 4–8 weeks. Minimally invasive approaches shorten these timelines significantly.
Will I need chemotherapy or radiotherapy after minimally invasive cancer surgery?
This depends on the final pathology report — stage, margins, lymph node involvement and molecular markers. The tumour board recommends adjuvant treatment personalised to your case.
What is the success rate of minimally invasive cancer surgery?
Outcomes depend on stage at diagnosis, tumour biology, surgical technique and adjuvant care. Early-stage cancers treated at experienced centres have very high cure rates — often above 80–90%.
Is minimally invasive minimally invasive cancer surgery available?
Yes. Laparoscopic and robotic approaches are offered whenever oncologically appropriate. These result in smaller incisions, less pain, faster recovery and equivalent cancer outcomes.
How much does minimally invasive cancer surgery cost in Chandigarh?
Cost varies based on approach, hospital, room category, duration of stay and complexity. Transparent estimates are provided at consultation and cashless insurance is coordinated wherever possible.
Can I get a second opinion?
Absolutely encouraged. Bring your reports, scans and biopsy slides — you will receive an honest, evidence-based opinion.

Book your consultation today

Get an honest, evidence-based opinion for minimally invasive cancer surgery from Chandigarh's leading surgical oncologist.

Book Appointment Call +91 62602 52120

Related Surgeries